Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to -$494000.0.

  • Ekso Bionics Holdings' Change in Inventory fell 79577.46% to -$494000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $50000.0, marking a year-over-year increase of 11592.36%. This contributed to the annual value of -$257000.0 for FY2024, which is 1077.59% down from last year.
  • Latest data reveals that Ekso Bionics Holdings reported Change in Inventory of -$494000.0 as of Q3 2025, which was down 79577.46% from $502000.0 recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year Change in Inventory high stood at $659000.0 for Q2 2022, and its period low was -$494000.0 during Q3 2025.
  • Moreover, its 5-year median value for Change in Inventory was $71000.0 (2024), whereas its average is $107894.7.
  • In the last 5 years, Ekso Bionics Holdings' Change in Inventory soared by 81630.43% in 2022 and then crashed by 79577.46% in 2025.
  • Ekso Bionics Holdings' Change in Inventory (Quarter) stood at $581000.0 in 2021, then crashed by 113.25% to -$77000.0 in 2022, then crashed by 411.69% to -$394000.0 in 2023, then increased by 14.47% to -$337000.0 in 2024, then tumbled by 46.59% to -$494000.0 in 2025.
  • Its Change in Inventory stands at -$494000.0 for Q3 2025, versus $502000.0 for Q2 2025 and $379000.0 for Q1 2025.